Search research articles
Contact Us
Filters
Showing results (41-50 of 54) with videos related to
Page
of 6
Sort By:
Cellular and Molecular Neurobiology
|
July 23, 2020
The Interplay of Tau Protein and β-Amyloid: While Tauopathy Spreads More Profoundly Than Amyloidopathy, Both Processes Are Almost Equally Pathogenic
Mahsa Pourhamzeh, Mohammad Taghi Joghataei, Soraya Mehrabi, et al.
Scientific Reports
|
May 4, 2021
Epilepsy lifetime prevalence in Iran: a large population- based national survey
Hossein Pakdaman, Ali Amini Harandi, Koroush Gharagozli, et al.
Cellular and Molecular Neurobiology
|
March 21, 2024
Retraction Note: The Interplay of Tau Protein and β-Amyloid: While Tauopathy Spreads More Profoundly Than Amyloidopathy, Both Processes Are Almost Equally Pathogenic
Mahsa Pourhamzeh, Mohammad Taghi Joghataei, Soraya Mehrabi, et al.
Medicine
|
June 19, 2023
MLC901 in hypoxic-ischemic brain injury patients: A double-blind, randomized placebo-controlled pilot study
Hossein Pakdaman, Koroush Gharagozli, Faezeh Karamiani, et al.
Scientific Reports
|
January 16, 2024
A randomized open-label clinical trial on the effect of Amantadine on post Covid 19 fatigue
Ali Amini Harandi, Hossein Pakdaman, Aida Medghalchi, et al.
Current Aging Science
|
February 27, 2023
A Long-term Study of NeuroAid (MLC601, MLC901) in Patients with Alzheimer's Disease; An Extension 8-year Follow-up Study
Hossein Pakdaman, Ali Amini Harandi, Koroush Gharagozli, et al.
Dementia and Geriatric Cognitive Disorders Extra
|
April 16, 2015
Effectiveness and Safety of MLC601 in the Treatment of Mild to Moderate Alzheimer's Disease: A Multicenter, Randomized Controlled Trial
Hossein Pakdaman, Ali Amini Harandi, Hamidreza Hatamian, et al.
Neuroimmunomodulation
|
August 18, 2022
Vascular Endothelial Growth Factor as a Predictive and Prognostic Biomarker for Multiple Sclerosis
Ali Amini Harandi, Fatemeh Siavoshi, Siavash Shirzadeh Barough, et al.
The International Journal of Neuroscience
|
June 10, 2016
Health-related quality of life in patients with relapsing-remitting multiple sclerosis treated with subcutaneous interferon β-1a in Iran
Hossein Pakdaman, Ali Amini Harandi, Koroush Gharagozli, et al.
The European Journal of Neuroscience
|
May 5, 2022
P38 initiates degeneration of midbrain GABAergic and glutamatergic neurons in diabetes models
Aisan Farhadi, Mehdi Totonchi, Seyed Masood Nabavi, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 54) with videos related to
Sort By:
Page
of 6
Cellular and Molecular Neurobiology
|
July 23, 2020
The Interplay of Tau Protein and β-Amyloid: While Tauopathy Spreads More Profoundly Than Amyloidopathy, Both Processes Are Almost Equally Pathogenic
Mahsa Pourhamzeh, Mohammad Taghi Joghataei, Soraya Mehrabi, et al.
Scientific Reports
|
May 4, 2021
Epilepsy lifetime prevalence in Iran: a large population- based national survey
Hossein Pakdaman, Ali Amini Harandi, Koroush Gharagozli, et al.
Cellular and Molecular Neurobiology
|
March 21, 2024
Retraction Note: The Interplay of Tau Protein and β-Amyloid: While Tauopathy Spreads More Profoundly Than Amyloidopathy, Both Processes Are Almost Equally Pathogenic
Mahsa Pourhamzeh, Mohammad Taghi Joghataei, Soraya Mehrabi, et al.
Medicine
|
June 19, 2023
MLC901 in hypoxic-ischemic brain injury patients: A double-blind, randomized placebo-controlled pilot study
Hossein Pakdaman, Koroush Gharagozli, Faezeh Karamiani, et al.
Scientific Reports
|
January 16, 2024
A randomized open-label clinical trial on the effect of Amantadine on post Covid 19 fatigue
Ali Amini Harandi, Hossein Pakdaman, Aida Medghalchi, et al.
Current Aging Science
|
February 27, 2023
A Long-term Study of NeuroAid (MLC601, MLC901) in Patients with Alzheimer's Disease; An Extension 8-year Follow-up Study
Hossein Pakdaman, Ali Amini Harandi, Koroush Gharagozli, et al.
Dementia and Geriatric Cognitive Disorders Extra
|
April 16, 2015
Effectiveness and Safety of MLC601 in the Treatment of Mild to Moderate Alzheimer's Disease: A Multicenter, Randomized Controlled Trial
Hossein Pakdaman, Ali Amini Harandi, Hamidreza Hatamian, et al.
Neuroimmunomodulation
|
August 18, 2022
Vascular Endothelial Growth Factor as a Predictive and Prognostic Biomarker for Multiple Sclerosis
Ali Amini Harandi, Fatemeh Siavoshi, Siavash Shirzadeh Barough, et al.
The International Journal of Neuroscience
|
June 10, 2016
Health-related quality of life in patients with relapsing-remitting multiple sclerosis treated with subcutaneous interferon β-1a in Iran
Hossein Pakdaman, Ali Amini Harandi, Koroush Gharagozli, et al.
The European Journal of Neuroscience
|
May 5, 2022
P38 initiates degeneration of midbrain GABAergic and glutamatergic neurons in diabetes models
Aisan Farhadi, Mehdi Totonchi, Seyed Masood Nabavi, et al.
Page
of 6